Canakinumab treat-to target strategies increase complete response rate in CAPS
Crossref DOI link: https://doi.org/10.1186/1546-0096-13-S1-P173
Published Online: 2015-09-28
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kuemmerle-Deschner, J
Hofer, F
Endres, T
Kortus-Goetze, B
Blank, N
Weißbarth-Riedel, E
Schuetz, C
Kallinich, T
Krause, K
Rietschel, C
Horneff, G
Benseler, SM
Article History
First Online: 28 September 2015